Valens GroWorks Corp (CSE:VGW), a BC-based, vertically-integrated provider of cannabis products, has signed a letter of intent (LOI) with Medigrowth Australia Pty. Ltd. Under the LOI, Valens with supply Medigrowth with premium cannabis flower and oil products that will then be sold and distributed across the Australian market. Valens will also be responsible for providing cultivation, extraction and lab service expertise for the support of research and development partnerships with Australian universities, governments and other organizations.
The LOI covers an initial three years, which will allow Medigrowth to apply any acquired knowledge to ongoing and future research and development opportunities.
In an article in The Province describing the LOI, Valens GroWorks CEO Tyler Robson is quoted as saying that “Medigrowth’s team is committed to investing in multidisciplinary research and development efforts with leading research institutions and governing bodies across Australia…In signing this letter of intent with Medigrowth, Valens secures a three-year supply partnership in the Australian market while strategically aligning ourselves with a company that shares in our commitment to innovation and premium product offerings to enhance patient care.”
To read the full article, click here.